Effects of Fusion Formulation Pelargonium sidoides and Arctii Fructus Extract on Acute Bronchitis

Pelargonium sidoides (Geraniaceae) has been used as a medicine for the treatment of respiratory diseases. And Arctii Fructus which dried fruits of Arcium lappa Linne (Compositae) has been widely used in Korea and China for the treatment of the various diseases including inflammation, fever, allergy and asthma. However, pharmacological study of these mixture have not been carried out until now. In this study, we investigated the improvement effects on acute bronchitis of HP02-A, which is formulated with P. sidoides 11% EtOH dried extract and Acrtii Fructus 50% EtOH dried extract in a 2 : 1 ratio. HP02-A significantly reduced the number of coughs and increased the dose-dependent promotion of sputum expectoration. In addition, HP02-A showed attenuation of inflammation in bronchoalveolar lavage fluid (BALF) and lung tissue. Furthermore, HP02-A also inhibited nitric oxide (NO) production in NCI-H292 cells. These results suggest that HP02-A has potential as a therapeutic agent for the treatment of acute bronchitis.

Authors

Publication Details

Journal
Korean Journal of Pharmacognosy
Published
2024-09-30
DOI
https://doi.org/10.22889/kjp.2024.55.3.151
Primary Topic
Respiratory and Cough-Related Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of Fusion Formulation Pelargonium sidoides and Arctii Fructus Extract on Acute Bronchitis

Yong‐Seong Kim, Dong‐Sung Lee, Dae Sung Kim
Korean Journal of Pharmacognosy
Respiratory and Cough-Related Research
article

Effects of Fusion Formulation Pelargonium sidoides and Arctii Fructus Extract on Acute Bronchitis

Yong‐Seong Kim, Dong‐Sung Lee, Dae Sung Kim
article en

Abstract

Pelargonium sidoides (Geraniaceae) has been used as a medicine for the treatment of respiratory diseases. And Arctii Fructus which dried fruits of Arcium lappa Linne (Compositae) has been widely used in Korea and China for the treatment of the various diseases including inflammation, fever, allergy and asthma. However, pharmacological study of these mixture have not been carried out until now. In this study, we investigated the improvement effects on acute bronchitis of HP02-A, which is formulated with P. sidoides 11% EtOH dried extract and Acrtii Fructus 50% EtOH dried extract in a 2 : 1 ratio. HP02-A significantly reduced the number of coughs and increased the dose-dependent promotion of sputum expectoration. In addition, HP02-A showed attenuation of inflammation in bronchoalveolar lavage fluid (BALF) and lung tissue. Furthermore, HP02-A also inhibited nitric oxide (NO) production in NCI-H292 cells. These results suggest that HP02-A has potential as a therapeutic agent for the treatment of acute bronchitis.

Korean Journal of PharmacognosyVol. 55(3)
Zero hunger
Openalex Percentile: Top 66%
Respiratory and Cough-Related Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.